166 related articles for article (PubMed ID: 10665126)
1. Treatment of complicated intra-abdominal infections: comparison of the tolerability and safety of intravenous/oral trovafloxacin versus intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid.
Luke DR; Peterson J
Int J Clin Pract; 1999; 53(3):166-73. PubMed ID: 10665126
[TBL] [Abstract][Full Text] [Related]
2. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
Donahue PE; Smith DL; Yellin AE; Mintz SJ; Bur F; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin.
Williams DJ; Hopkins S
Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261
[TBL] [Abstract][Full Text] [Related]
4. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Niinikoski J; Havia T; Alhava E; Pääkkönen M; Miettinen P; Kivilaakso E; Haapiainen R; Matikainen M; Laitinen S
Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
[TBL] [Abstract][Full Text] [Related]
7. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
Basoli A; Meli EZ; Mazzocchi P; Speranza V
Scand J Infect Dis; 1997; 29(5):503-8. PubMed ID: 9435041
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group.
Roy S; Koltun W; Chatwani A; Martens MG; Dittrich R; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):67S-73S. PubMed ID: 9935260
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
[TBL] [Abstract][Full Text] [Related]
11. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
[TBL] [Abstract][Full Text] [Related]
12. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
[TBL] [Abstract][Full Text] [Related]
13. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
[TBL] [Abstract][Full Text] [Related]
14. Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis.
Gomis M; Barberán J; Sánchez B; Khorrami S; Borja J; García-Barbal J
Rev Esp Quimioter; 1999 Sep; 12(3):244-9. PubMed ID: 10878516
[TBL] [Abstract][Full Text] [Related]
15. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
Ball P; Mandell L; Patou G; Dankner W; Tillotson G
Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin: an updated review of its use in the treatment of bacterial infections.
Hurst M; Lamb HM; Scott LJ; Figgitt DP
Drugs; 2002; 62(14):2127-67. PubMed ID: 12269858
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Croom KF; Goa KL
Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
[TBL] [Abstract][Full Text] [Related]
18. The role of oral antimicrobials for the management of intra-abdominal infections.
Solomkin JS; Dellinger EP; Bohnen JM; Rostein OD
New Horiz; 1998 May; 6(2 Suppl):S46-52. PubMed ID: 9654311
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
20. Pradofloxacin in the treatment of canine deep pyoderma: a multicentred, blinded, randomized parallel trial.
Mueller RS; Stephan B
Vet Dermatol; 2007 Jun; 18(3):144-51. PubMed ID: 17470228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]